IQVIA's Investor Day Next Catalyst Following Q3 Beat, RBC Says

12:41 PM EDT, 10/28/2026 (MT Newswires) -- IQVIA (IQV) beat Q3 expectations and raised guidance, with its investor day set to be the next catalyst, RBC Capital Markets said in a note Tuesday. Key macroeconomic indicators are showing high-single-digit growth, while the company continues to benefit from its differentiated data analytics capabilities, including artificial intelligence, the analysts said. The analysts added they expect AI to remain a net tailwind for IQVIA as biopharmaceutical companies seek outsourced research and development capacity, speed, and improved success rates. The next key catalyst is IQVIA's investor day on Dec. 1, when the company is expected to outline its 2027 growth framework, provide a long-range plan, and discuss how AI and data analytics could support growth, the analysts said, adding that more detailed 2027 guidance is expected with the company's Q4 earnings report. RBC kept its outperform rating and $319 price target on IQVIA. Price: 276.51, Change: +4.96, Percent Change: +1.83